Eating disorders are on the rise. GLP-1s could make things worse.
· technologyreview.com · popularity 21/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at technologyreview.com →
Summary
GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinical psychologists, they can represent something more sinister—a potential trigger for eating disorders. A new report suggests that the global incidence of anorexia nervosa and bulimia nervosa shot up between 1990 and 2023—by a whopping 71%. By 2023,…
Found in: MIT Technology Review. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 2.